Skip to main content
Clinical Trials/NCT00574301
NCT00574301
Completed
Phase 1

Percutaneous Removal and Margin Ablation for Breast Cancer

University of Arkansas1 site in 1 country32 target enrollmentMarch 2002
ConditionsBreast Cancer

Overview

Phase
Phase 1
Intervention
Not specified
Conditions
Breast Cancer
Sponsor
University of Arkansas
Enrollment
32
Locations
1
Primary Endpoint
To quantify the degree of tumor-free margin achieved with image-guided vacuum assisted biopsy followed by ablation with radiofrequency ablation
Status
Completed
Last Updated
12 years ago

Overview

Brief Summary

We hypothesize that radiofrequency ablation after single-insertion image guided vacuum assisted biopsy (IVEB) can be used to achieve negative margins in small unicentric breast cancers (≤1.5 cm).

Detailed Description

Using the Mammotome Breast Biopsy System (IVEB) in conjunction with MRI to predict extent of disease, ultrasound to direct removal of the tumor, touch preparation cytology for diagnosis, and ablation of margins using radiofrequency ablation (RFA), we propose to develop a comprehensive system for same-day diagnosis and treatment of patients with small breast lesions.

Registry
clinicaltrials.gov
Start Date
March 2002
End Date
October 2011
Last Updated
12 years ago
Study Type
Interventional
Study Design
Single Group
Sex
Female

Investigators

Responsible Party
Sponsor

Eligibility Criteria

Inclusion Criteria

  • Female, 18 to 90 years of age
  • Non-pregnant, not breastfeeding
  • Pre-study documentation of:
  • Size ≤1.5 cm cancer successfully removed by US-guided IVEB within 30 days of registration
  • Uni-centricity, unilateral cancer by radiology (mammogram and MRI)
  • Location of abnormality \> 1 cm from the skin
  • Ductal Carcinoma, Invasive (Grade I-III) or In-Situ
  • No palpable axillary or supraclavicular lymph nodes
  • Good general health
  • Zubrod Performance Status of 0, 1, or 2

Exclusion Criteria

  • Subjects less than 18 years of age or greater than 90 years of age
  • Pregnant or breastfeeding
  • Prior Breast Biopsy affected breast
  • Breast implants
  • Multicentric disease, bilateral disease
  • Residual disease after IVEB of \> 1cm on MRI
  • Lesions \> 1.5 cm in diameter
  • Lesions \< 1 cm from skin surface
  • Previous radiation therapy to the breast

Outcomes

Primary Outcomes

To quantify the degree of tumor-free margin achieved with image-guided vacuum assisted biopsy followed by ablation with radiofrequency ablation

Time Frame: Post-surgical pathology review

Secondary Outcomes

  • The proportion of patients with viable tumor cells beyond the margin(Post-surgical pathology review)

Study Sites (1)

Loading locations...

Similar Trials